Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Cascinelli

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Melanoma Research|November 1, 1992
Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot studyF Belli, F Arienti, L Rivoltini, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I studyA Balsari, R Marolda, C Gambacorti-Passerini, et al.
Tumori|June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patientsN Cascinelli, F Belli, S Marchini, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studiesG Parmiani, M L Sensi, A Balsari, et al.
Breast Cancer Research and Treatment|September 11, 1999
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviorsS Ménard, P Casalini, G Tomasic, et al.
Annals of Surgery|January 1, 1987
A reappraisal of oophorectomy in carcinoma of the breastU Veronesi, N Cascinelli, M Greco, et al.
Cancer|January 15, 1994
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalanM Vaglini, F Belli, M Ammatuna, et al.
International Journal of Cancer|May 15, 1988
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2C Gambacorti-Passerini, M Radrizzani, R Marolda, et al.
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1984
Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigenG L Buraggi, L Callegaro, A Turrin, et al.
Annals of Surgical Oncology|January 1, 1995
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanomaM Vaglini, F Belli, M Santinami, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Melanoma Research|November 1, 1992
Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot studyF Belli, F Arienti, L Rivoltini, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I studyA Balsari, R Marolda, C Gambacorti-Passerini, et al.
Tumori|June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patientsN Cascinelli, F Belli, S Marchini, et al.
La Ricerca in Clinica E in Laboratorio|January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studiesG Parmiani, M L Sensi, A Balsari, et al.
Breast Cancer Research and Treatment|September 11, 1999
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviorsS Ménard, P Casalini, G Tomasic, et al.
Annals of Surgery|January 1, 1987
A reappraisal of oophorectomy in carcinoma of the breastU Veronesi, N Cascinelli, M Greco, et al.
Cancer|January 15, 1994
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalanM Vaglini, F Belli, M Ammatuna, et al.
International Journal of Cancer|May 15, 1988
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2C Gambacorti-Passerini, M Radrizzani, R Marolda, et al.
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1984
Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigenG L Buraggi, L Callegaro, A Turrin, et al.
Annals of Surgical Oncology|January 1, 1995
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanomaM Vaglini, F Belli, M Santinami, et al.
Pageof 19